A Study to Evaluate ALN-AGT01 in Patients With Hypertension

NCT03934307 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: ALN-AGT01
DRUG: ALN-AGT01-Matching Placebo
DRUG: Irbesartan
DRUG: Irbesartan-Matching Placebo

Sponsor

Alnylam Pharmaceuticals